about
Evidence by expression analysis of candidate genes for congenital heart defects in the NF1 microdeletion intervalClinical score of 62 Italian patients with Cornelia de Lange syndrome and correlations with the presence and type of NIPBL mutationDelineating the cytogenomic and epigenomic landscapes of glioma stem cell linesRubinstein-Taybi Syndrome: spectrum of CREBBP mutations in Italian patients.Chromosomal aberrations in bladder cancer: fresh versus formalin fixed paraffin embedded tissue and targeted FISH versus wide microarray-based CGH analysis.Chromosomal imbalances in human bladder urothelial carcinoma: similarities and differences between biopsy samples and cancer stem-like cellsEvidence for non-homologous end joining and non-allelic homologous recombination in atypical NF1 microdeletions.Cytogenetics of premature ovarian failure: an investigation on 269 affected women.Investigating the role of X chromosome breakpoints in premature ovarian failure.Resveratrol Impairs Glioma Stem Cells Proliferation and Motility by Modulating the Wnt Signaling PathwayThe Effect of Culture on Human Bone Marrow Mesenchymal Stem Cells: Focus on DNA Methylation Profiles.From cytogenomic to epigenomic profiles: monitoring the biologic behavior of in vitro cultured human bone marrow mesenchymal stem cells.Using Copy Number Alterations to Identify New Therapeutic Targets for Bladder Carcinoma.Monitoring the genomic stability of in vitro cultured rat bone-marrow-derived mesenchymal stem cells.DNA Methylation Changes during In Vitro Propagation of Human Mesenchymal Stem Cells: Implications for Their Genomic Stability?Thyrospheres from B-CPAP Cell Line with BRAF and TERT Promoter Mutations have Different Functional and Molecular Features than Parental Cells.Epigenetic targeting of glioma stem cells: Short-term and long-term treatments with valproic acid modulate DNA methylation and differentiation behavior, but not temozolomide sensitivity.Distinct pools of cancer stem-like cells coexist within human glioblastomas and display different tumorigenicity and independent genomic evolution.In vitro anticancer drug test: A new method emerges from the model of glioma stem cells.Pioglitazone Effect on Glioma Stem Cell Lines: Really a Promising Drug Therapy for Glioblastoma?FISH with locus-specific probes on stretched chromosomes: a useful tool for genome organization studies.Epigenetic and transcriptional modulation of WDR5, a chromatin remodeling protein, in Huntington's disease human induced pluripotent stem cell (hiPSC) model.Analysis of Chromosomal Alterations in Urothelial Carcinoma.Prenatal/neonatal pathology in two cases of Cornelia de Lange syndrome harboring novel mutations of NIPBL.High frequency of mosaic CREBBP deletions in Rubinstein-Taybi syndrome patients and mapping of somatic and germ-line breakpoints.Valproic Acid Inhibits Proliferation and Reduces Invasiveness in Glioma Stem Cells Through Wnt/β Catenin Signalling ActivationBiological heterogeneity of putative bladder cancer stem-like cell populations from human bladder transitional cell carcinoma samplesTandem duplication of the NF1 gene detected by high-resolution FISH in the 17q11.2 regionIdentification of duplicated genes in 17q11.2 using FISH on stretched chromosomes and DNA fibersSpecific Expression of a New Bruton Tyrosine Kinase Isoform (p65BTK) in the Glioblastoma Gemistocytic HistotypeA de novo supernumerary genomic discontinuous ring chromosome 21 in a child with mild intellectual disabilityRefining the Phenotype of Recurrent Rearrangements of Chromosome 16Role of Notch Signaling Pathway in Glioblastoma PathogenesisA Ploidy Increase Promotes Sensitivity of Glioma Stem Cells to Aurora Kinases InhibitionUGT1A1 mutations and psychoses: towards understanding the relationship with unconjugated bilirubin
P50
Q24319746-C7499F70-55A7-4843-9780-42A6F9C37F8CQ28238402-D5572CA3-9A40-4C36-B0AF-5B1F0B2385C8Q31112229-E3E2DCA8-B801-4532-B1BC-1F64783CEB2DQ33260914-52FB234B-CB69-47E7-84AD-8DA8B457D36EQ34016615-5CD576DA-3E35-4FEA-B379-497F650FD3F2Q34174124-39078665-DF4F-4352-8221-2E22D1F2696AQ34315709-106ECCBF-D5DA-4141-8315-538B8D422BA5Q34521311-8B42F946-4C08-4068-8FD1-52EF960E17DCQ36237122-D7EB1DB1-5191-4DBA-AE19-9E1982E32F91Q36247757-F422A6F4-4976-43D1-A508-07E721B42954Q36530781-FD0321FA-5554-41E8-902F-4F5F70BB0DF2Q36633035-48CA0F81-9B68-4FDF-A1FA-240CD23DA944Q36743446-7E53AEBE-E450-4AC3-813D-0A4A3F72D0E3Q37475659-79B3253D-02F6-4EBA-AD78-2856B5722946Q38167313-6C30E5FC-563D-4C31-80E3-85F66056DA51Q38695744-F1E1312A-7F4D-498D-AD56-D30089A97B55Q38785518-A47933D4-DC9F-4E37-A623-88A1875FD5C5Q39872681-3F3447D6-55BA-43CA-95F9-335273B671C4Q41681466-0F0EBB55-EBEF-4570-8D29-9B4E06776B1CQ42737831-F59E7FBA-5E1C-4235-9C54-6F886FC21D1CQ43587721-F992EF38-FBAA-4BF8-8677-6C25C826FE63Q45302039-C19CD536-780A-407E-AFF0-99EF4695F797Q50182700-F74C177F-6D22-4F14-AEDA-58633D897FF7Q51905127-5411A7B0-63C0-4BF9-966E-A67F944DC92CQ53527995-881EBAD9-5F55-48AB-B15D-C951978B4877Q58114002-F0378FBD-9CAC-4DE8-8DE7-5F194779C67FQ59484935-1D01D9DF-5057-4794-88AA-E87EFCAF0406Q61549018-E4DE576E-54F2-4050-BA1E-1ACCEF081CA7Q61549052-B1E29F18-E436-40EC-895A-5EAA2E54E1AAQ61810285-EB05F7A4-C326-45E5-ACAB-AA9ED35DEE99Q61812469-47ECEEBE-A804-491B-9ABB-C6849C653BA6Q64068161-7549F80D-DD31-426D-B034-B13416532358Q64075342-34AF75AB-6108-4BD7-A8F1-61B90F99EBCEQ90150446-7BB6BEE5-E32C-40AE-8984-38D0DFE9B7C4Q92142442-0AF617C7-E10D-4FF8-9FFE-38FC3F41027F
P50
description
hulumtuese
@sq
researcher
@en
ricercatrice
@it
wetenschapper
@nl
հետազոտող
@hy
name
Angela Bentivegna
@ast
Angela Bentivegna
@en
Angela Bentivegna
@es
Angela Bentivegna
@nl
type
label
Angela Bentivegna
@ast
Angela Bentivegna
@en
Angela Bentivegna
@es
Angela Bentivegna
@nl
prefLabel
Angela Bentivegna
@ast
Angela Bentivegna
@en
Angela Bentivegna
@es
Angela Bentivegna
@nl
P214
P106
P1153
57190110892
P21
P214
P31
P396
IT\ICCU\CFIV\272952
P496
0000-0001-7535-846X
P569
1971-01-01T00:00:00Z